5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
SELL | SELL | SELL | SELL | SELL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 2.08▼ | 2.08▼ | 2.08▼ | 2.08▼ | 2.08▼ |
MA10 | 2.08▼ | 2.08▼ | 2.08▼ | 2.08▼ | 2.02▲ |
MA20 | 2.08▼ | 2.09▼ | 2.09▼ | 2.08▼ | 2.27▼ |
MA50 | 2.09▼ | 2.09▼ | 2.08▼ | 2.05▲ | 2.89▼ |
MA100 | 2.09▼ | 2.08▼ | 2.08▼ | 2.31▼ | N/A |
MA200 | 2.09▼ | 2.08▼ | 2.04▲ | 2.75▼ | N/A |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | -0.001▼ | -0.002▼ | -0.002▼ | 0.001▲ | 0.027▲ |
RSI | 23.739▼ | 29.603▼ | 31.906▼ | 49.519▼ | 42.412▼ |
STOCH | 20.833 | 11.667▼ | 8.889▼ | 41.667 | 55.995 |
WILL %R | -80.000▼ | -83.333▼ | -85.714▼ | -83.333▼ | -51.215 |
CCI | -229.091▼ | -198.765▼ | -175.000▼ | -70.000 | -27.601 |
Monday, September 29, 2025 12:59 PM
The report adds that Rezolve AI is "faking ARR growth by acquiring failing AI start-ups with declining revenue," including an undisclosed acquisition of ViSenze, a “failing” Singapore AI company.
|
Tuesday, September 23, 2025 05:05 PM
Mural Oncology plc, (Nasdaq: MURA) (“Mural”), a clinical-stage immuno-oncology company, today announces for the purposes of the Irish Takeover Panel Act, 1997, Takeover Rules 2022 (the “Irish Takeover ...
|
Thursday, August 28, 2025 09:24 AM
NEW YORK, Aug. 28, 2025 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
30/09/25 | 2.08 | 2.09 | 2.06 | 2.07 | 229,976 |
29/09/25 | 2.08 | 2.09 | 2.08 | 2.08 | 44,131 |
26/09/25 | 2.09 | 2.10 | 2.08 | 2.09 | 268,183 |
25/09/25 | 2.10 | 2.12 | 2.09 | 2.09 | 174,433 |
24/09/25 | 2.09 | 2.10 | 2.08 | 2.09 | 187,549 |
23/09/25 | 2.07 | 2.10 | 2.07 | 2.09 | 226,205 |
22/09/25 | 2.07 | 2.08 | 2.07 | 2.07 | 121,065 |
19/09/25 | 2.07 | 2.08 | 2.07 | 2.08 | 237,916 |
18/09/25 | 2.08 | 2.08 | 2.07 | 2.08 | 116,467 |
17/09/25 | 2.07 | 2.08 | 2.07 | 2.08 | 200,387 |
|
|
||||
|
|
||||
|
|